FTC sues main pharmacy benefit administrators over insulin costs The company introduced action towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of life-preserving insulin medications. Elevance lowers assistance on ‘unprecedented’ Medicaid challenges Executives explained the impr... https://dave-s-hot-chicken-nutrit82726.wssblogs.com/30672091/healthcare-news-secrets